Selected research
Market Outlook & Growth Opportunities
Global Lipid Nanoparticle (LNP) Encapsulation Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Lipid Nanoparticle (LNP) Encapsulation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Lipid Nanoparticle (LNP) Encapsulation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lipid Nanoparticle (LNP) Encapsulation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lipid Nanoparticle (LNP) Encapsulation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Lipid Nanoparticle (LNP) Encapsulation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Lipid Nanoparticle (LNP) Encapsulation Services market include Lonza, Merck, Thermo Fisher Scientific, CordenPharma, FUJIFILM Pharma, BioCina, Catalent, Evonik Health Care and Biomay, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Lipid Nanoparticle (LNP) Encapsulation Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lipid Nanoparticle (LNP) Encapsulation Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lipid Nanoparticle (LNP) Encapsulation Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lipid Nanoparticle (LNP) Encapsulation Services market.
Lipid Nanoparticle (LNP) Encapsulation Services Segment by Company
Lonza
Merck
Thermo Fisher Scientific
CordenPharma
FUJIFILM Pharma
BioCina
Catalent
Evonik Health Care
Biomay
GenScript
GENEWIZ
Fluidiclab
Perfect mRNA
Synbio Technologies
Geneseed Biotech
Micro&Nano
Lipid Nanoparticle (LNP) Encapsulation Services Segment by Type
Nucleic Acid Encapsulation Service
Small-Molecule Drug Encapsulation Service
Protein And Peptide Encapsulation Service
Lipid Nanoparticle (LNP) Encapsulation Services Segment by Application
Biopharmaceutical
Cosmetic and Personal Care
Others
Lipid Nanoparticle (LNP) Encapsulation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Lipid Nanoparticle (LNP) Encapsulation Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Lipid Nanoparticle (LNP) Encapsulation Services key companies, revenue, market share, and recent developments.
3. To split the Lipid Nanoparticle (LNP) Encapsulation Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Lipid Nanoparticle (LNP) Encapsulation Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Lipid Nanoparticle (LNP) Encapsulation Services significant trends, drivers, influence factors in global and regions.
6. To analyze Lipid Nanoparticle (LNP) Encapsulation Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Encapsulation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Encapsulation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Encapsulation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lipid Nanoparticle (LNP) Encapsulation Services industry.
Chapter 3: Detailed analysis of Lipid Nanoparticle (LNP) Encapsulation Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Lipid Nanoparticle (LNP) Encapsulation Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Lipid Nanoparticle (LNP) Encapsulation Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Encapsulation Service
- Small-Molecule Drug Encapsulation Service
- Protein And Peptide Encapsulation Service
Applications
- Biopharmaceutical
- Cosmetic and Personal Care
- Others
Companies covered
- Lonza
- Merck
- Thermo Fisher Scientific
- CordenPharma
- FUJIFILM Pharma
- BioCina
- Catalent
- Evonik Health Care
- Biomay
- GenScript
- GENEWIZ
- Fluidiclab
- Perfect mRNA
- Synbio Technologies
- Geneseed Biotech
- Micro&Nano
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Lipid Nanoparticle (LNP) Encapsulation Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Lipid Nanoparticle (LNP) Encapsulation Services Market Dynamics
- 2.1 Lipid Nanoparticle (LNP) Encapsulation Services Industry Trends
- 2.2 Lipid Nanoparticle (LNP) Encapsulation Services Industry Drivers
- 2.3 Lipid Nanoparticle (LNP) Encapsulation Services Industry Opportunities and Challenges
- 2.4 Lipid Nanoparticle (LNP) Encapsulation Services Industry Restraints
3 Lipid Nanoparticle (LNP) Encapsulation Services Market by Company
- 3.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Company Revenue Ranking in 2025
- 3.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Revenue by Company (2021-2026)
- 3.3 Global Lipid Nanoparticle (LNP) Encapsulation Services Company Ranking (2024-2026)
- 3.4 Global Lipid Nanoparticle (LNP) Encapsulation Services Company Manufacturing Base and Headquarters
- 3.5 Global Lipid Nanoparticle (LNP) Encapsulation Services Company Product Type and Application
- 3.6 Global Lipid Nanoparticle (LNP) Encapsulation Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Lipid Nanoparticle (LNP) Encapsulation Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Lipid Nanoparticle (LNP) Encapsulation Services Market by Type
- 4.1 Lipid Nanoparticle (LNP) Encapsulation Services Type Introduction
- 4.1.1 Nucleic Acid Encapsulation Service
- 4.1.2 Small-Molecule Drug Encapsulation Service
- 4.1.3 Protein And Peptide Encapsulation Service
- 4.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Type
- 4.2.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Type (2021-2032)
- 4.2.3 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type (2021-2032)
5 Lipid Nanoparticle (LNP) Encapsulation Services Market by Application
- 5.1 Lipid Nanoparticle (LNP) Encapsulation Services Application Introduction
- 5.1.1 Biopharmaceutical
- 5.1.2 Cosmetic and Personal Care
- 5.1.3 Others
- 5.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Application
- 5.2.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Application (2021-2032)
- 5.2.3 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application (2021-2032)
6 Lipid Nanoparticle (LNP) Encapsulation Services Regional Value Analysis
- 6.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Region (2021-2032)
- 6.2.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Region: 2021-2026
- 6.2.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lipid Nanoparticle (LNP) Encapsulation Services Sales Value (2021-2032)
- 6.3.2 North America Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Lipid Nanoparticle (LNP) Encapsulation Services Sales Value (2021-2032)
- 6.4.2 Europe Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Lipid Nanoparticle (LNP) Encapsulation Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Lipid Nanoparticle (LNP) Encapsulation Services Sales Value (2021-2032)
- 6.6.2 South America Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Lipid Nanoparticle (LNP) Encapsulation Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Country, 2025 VS 2032
7 Lipid Nanoparticle (LNP) Encapsulation Services Country-level Value Analysis
- 7.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Country (2021-2032)
- 7.2.1 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Country (2021-2026)
- 7.2.2 Global Lipid Nanoparticle (LNP) Encapsulation Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Lipid Nanoparticle (LNP) Encapsulation Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Lonza
- 8.1.1 Lonza Company Information
- 8.1.2 Lonza Business Overview
- 8.1.3 Lonza Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Lonza Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.1.5 Lonza Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 Thermo Fisher Scientific
- 8.3.1 Thermo Fisher Scientific Company Information
- 8.3.2 Thermo Fisher Scientific Business Overview
- 8.3.3 Thermo Fisher Scientific Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Thermo Fisher Scientific Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.3.5 Thermo Fisher Scientific Recent Developments
- 8.4 CordenPharma
- 8.4.1 CordenPharma Company Information
- 8.4.2 CordenPharma Business Overview
- 8.4.3 CordenPharma Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.4.4 CordenPharma Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.4.5 CordenPharma Recent Developments
- 8.5 FUJIFILM Pharma
- 8.5.1 FUJIFILM Pharma Company Information
- 8.5.2 FUJIFILM Pharma Business Overview
- 8.5.3 FUJIFILM Pharma Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.5.4 FUJIFILM Pharma Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.5.5 FUJIFILM Pharma Recent Developments
- 8.6 BioCina
- 8.6.1 BioCina Company Information
- 8.6.2 BioCina Business Overview
- 8.6.3 BioCina Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.6.4 BioCina Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.6.5 BioCina Recent Developments
- 8.7 Catalent
- 8.7.1 Catalent Company Information
- 8.7.2 Catalent Business Overview
- 8.7.3 Catalent Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Catalent Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.7.5 Catalent Recent Developments
- 8.8 Evonik Health Care
- 8.8.1 Evonik Health Care Company Information
- 8.8.2 Evonik Health Care Business Overview
- 8.8.3 Evonik Health Care Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Evonik Health Care Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.8.5 Evonik Health Care Recent Developments
- 8.9 Biomay
- 8.9.1 Biomay Company Information
- 8.9.2 Biomay Business Overview
- 8.9.3 Biomay Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Biomay Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.9.5 Biomay Recent Developments
- 8.10 GenScript
- 8.10.1 GenScript Company Information
- 8.10.2 GenScript Business Overview
- 8.10.3 GenScript Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.10.4 GenScript Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.10.5 GenScript Recent Developments
- 8.11 GENEWIZ
- 8.11.1 GENEWIZ Company Information
- 8.11.2 GENEWIZ Business Overview
- 8.11.3 GENEWIZ Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.11.4 GENEWIZ Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.11.5 GENEWIZ Recent Developments
- 8.12 Fluidiclab
- 8.12.1 Fluidiclab Company Information
- 8.12.2 Fluidiclab Business Overview
- 8.12.3 Fluidiclab Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Fluidiclab Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.12.5 Fluidiclab Recent Developments
- 8.13 Perfect mRNA
- 8.13.1 Perfect mRNA Company Information
- 8.13.2 Perfect mRNA Business Overview
- 8.13.3 Perfect mRNA Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Perfect mRNA Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.13.5 Perfect mRNA Recent Developments
- 8.14 Synbio Technologies
- 8.14.1 Synbio Technologies Company Information
- 8.14.2 Synbio Technologies Business Overview
- 8.14.3 Synbio Technologies Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Synbio Technologies Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.14.5 Synbio Technologies Recent Developments
- 8.15 Geneseed Biotech
- 8.15.1 Geneseed Biotech Company Information
- 8.15.2 Geneseed Biotech Business Overview
- 8.15.3 Geneseed Biotech Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Geneseed Biotech Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.15.5 Geneseed Biotech Recent Developments
- 8.16 Micro&Nano
- 8.16.1 Micro&Nano Company Information
- 8.16.2 Micro&Nano Business Overview
- 8.16.3 Micro&Nano Lipid Nanoparticle (LNP) Encapsulation Services Revenue and Gross Margin (2021-2026)
- 8.16.4 Micro&Nano Lipid Nanoparticle (LNP) Encapsulation Services Product Portfolio
- 8.16.5 Micro&Nano Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst